JO2334B1 - Drospirenone for hormone replacement therapy - Google Patents
Drospirenone for hormone replacement therapyInfo
- Publication number
- JO2334B1 JO2334B1 JO200110A JOP20010010A JO2334B1 JO 2334 B1 JO2334 B1 JO 2334B1 JO 200110 A JO200110 A JO 200110A JO P20010010 A JOP20010010 A JO P20010010A JO 2334 B1 JO2334 B1 JO 2334B1
- Authority
- JO
- Jordan
- Prior art keywords
- estrogen
- beta
- menopausal
- drospirenone
- hormone replacement
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A pharmaceutical composition comprising as a first active ingredient an estrogen, such as estradiol or estradiol valerate, in sufficient amounts to treat disorders and symptoms associated with deficient endogenous levels of estrogen in women, and as a second active ingredient 6 beta , 7 beta ; 15 beta ; 16 beta -dimethylene-3-oxo-17 alpha -preg-4-ene-21, 17-carbolactone (drospirenone, DRSP) in sufficient amounts to protect the endometrium from the adverse effects of estrogen is useful for, amongst others, treating peri-menopausal, menopausal and post-menopausal women. This composition may be used for hormone replacement therapy and may be administered as a multi-phased pharmaceutical preparation. This combination therapy may comprise continuous, sequential or interrupted administration, or combinations thereof, of DRSP and estrogen, each optionally in micronized form.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00200183 | 2000-01-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JO2334B1 true JO2334B1 (en) | 2006-06-28 |
Family
ID=38170612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JO200110A JO2334B1 (en) | 2000-01-18 | 2001-01-11 | Drospirenone for hormone replacement therapy |
Country Status (7)
| Country | Link |
|---|---|
| AR (1) | AR035633A1 (en) |
| CO (1) | CO5280075A1 (en) |
| HR (1) | HRP20070360B1 (en) |
| JO (1) | JO2334B1 (en) |
| PE (1) | PE20011051A1 (en) |
| SA (1) | SA01210754B1 (en) |
| UA (2) | UA89180C2 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4426601A1 (en) * | 1994-07-27 | 1996-02-01 | Schering Ag | Use of a combination product containing a competitive progesterone antagonist and a progestogen for the manufacture of a medicament for the treatment of endometriosis or Leiomyomata uteri |
| DE19654609A1 (en) * | 1996-12-20 | 1998-06-25 | Schering Ag | Therapeutic progestogens for the treatment of premenstrual dysphoric disorder |
| DK1380301T3 (en) * | 1999-08-31 | 2009-04-20 | Bayer Schering Pharma Ag | Pharmaceutical composition of ethinylestradiol and drospirenone for use as a contraceptive |
-
2001
- 2001-01-11 JO JO200110A patent/JO2334B1/en active
- 2001-01-15 PE PE2001000035A patent/PE20011051A1/en active IP Right Grant
- 2001-01-17 CO CO01003045A patent/CO5280075A1/en not_active Application Discontinuation
- 2001-01-17 AR ARP010100199 patent/AR035633A1/en not_active Application Discontinuation
- 2001-01-18 UA UAA200612100A patent/UA89180C2/en unknown
- 2001-01-18 UA UA2002086809A patent/UA81388C2/en unknown
- 2001-03-21 SA SA01210754A patent/SA01210754B1/en unknown
-
2007
- 2007-08-17 HR HRP20070360AA patent/HRP20070360B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20070360B1 (en) | 2014-11-21 |
| PE20011051A1 (en) | 2001-10-17 |
| UA89180C2 (en) | 2010-01-11 |
| UA81388C2 (en) | 2008-01-10 |
| AR035633A1 (en) | 2004-06-23 |
| CO5280075A1 (en) | 2003-05-30 |
| HRP20070360A2 (en) | 2008-12-31 |
| SA01210754B1 (en) | 2007-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU54602A (en) | Drospirenone for hormone replacement therapy | |
| MADANES et al. | Danazol | |
| NZ516502A (en) | Administration of non-oral androgenic steroids to women having an elevated level of sex hormone binding globulin (SHBG) | |
| CA2205897A1 (en) | Compositions and methods for contraception and for treatment of benign gynecological disorders | |
| KR20090080989A (en) | USE OF ESTRADIOL VALERATE OR 17beta-ESTRADIOL IN COMBINATION WITH DIENOGEST FOR ORAL THERAPY FOR MAINTAINING AND/OR INCREASING THE FEMALE LIBIDO | |
| WO1996019997A1 (en) | Compounds with progesterone-antagonistic and anti-oestrogen properties intended for combined use in female contraception | |
| US20110009373A1 (en) | Composition comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis | |
| Thorneycroft | Update on androgenicity | |
| TR199900764T2 (en) | A hormonal composition consisting of an estrogen compound and a progestational compound. | |
| JO2334B1 (en) | Drospirenone for hormone replacement therapy | |
| Shulman | A review of drospirenone for safety and tolerability and effects on endometrial safety and lipid parameters contrasted with medroxyprogesterone acetate, levonorgestrel, and micronized progesterone | |
| CA2248841C (en) | Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy | |
| Whitehead | Hormone replacement therapy with estradiol and drospirenone: an overview of the clinical data | |
| HRP20020666A8 (en) | Drospirenone for hormone replacement therapy | |
| Schindler | Antriandrogen therapy for signs of androgenization: an overview | |
| Schindler | COMPOUND CEMICAL STRUCTURE Cimetidine Flutamide | |
| TH134365B (en) | Drospirinone for hormone replacement therapy | |
| MXPA98007513A (en) | Sequencial combination of estrogen / antagonist of progesterone for therapy of replacement of hormo | |
| DE10134768A1 (en) | Pharmaceutical combination preparations containing aromatase inhibitors and substances with an estrogenic effect and their use | |
| AU5942700A (en) | Sequential estrogen/progestrone antagonist combination for hormone replacement theapy | |
| MXPA01008772A (en) | Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding | |
| TH134365A (en) | Drospirinone for hormone replacement therapy |